baber/WOPTO huggingface dataset:
Patent FI-913912-A0 (FI)
Inventor: O'NEIL ALEXANDER GEORGE BRIAN
IPC: A61M39/10
Filed: 1991-08-19
Abstract: PCT No. PCT/GB90/02012 Sec. 371 Date Sep. 2, 1992 Sec. 102(e) Date Sep. 2, 1992 PCT Filed Dec. 21, 1990 PCT Pub. No. WO91/10861 PCT Pub. Date Jul. 25, 1991.A fluid coupling for connecting a plurality of fluid sources to a single-bore outlet member, said coupling comprising a plurality of tubes (44, 46, 48) mutually conjoined within a connector (42) for attachment of said outlet member, each said tube extending through said connector to terminate at a point (43) which is substantially contiguous with said outlet member when attached to said connector, the lumens of each said tube being mutually isolated by the tube walls until the termination of the tubes at said point, whereby in use of said fluid coupling with said single-bore outlet member connected thereto, fluid passing down any of said tubes discharges from the end of the respective tube substantially directly into the bore of said outlet member.
Patent FI-925034-A0 (FI)
Inventor: WEINSHANK RICHARD L
IPC: A01K67/027
Filed: 1992-11-06
Abstract: This invention provides isolated nucleic acid molecules encoding human 5-HT1D receptors, isolated proteins which are human 5-HT1D receptors, vectors comprising isolated nucleic acid molecules encoding human 5-HT1D receptors, mammalian cells comprising such vectors, antibodies directed to the human 5-HT1D receptors, nucleic acid probes useful for detecting nucleic acid encoding human 5-HT1D receptors, antisense oligonucleotides complementary to any sequences of a nucleic acid molecule which encodes a human 5-HT1D receptor, pharmaceutical compounds related to human 5-HT1D receptors, and nonhuman transgenic animals which express DNA a normal or a mutant human 5-HT1D receptor. This invention further provides methods for determining ligand binding, detecting expression, drug screening, and treatment involving the human 5-HT1D receptor.
Patent FI-931483-A0 (FI)
Inventor: GLOESENER DANIEL
IPC: C08L51/00
Filed: 1993-04-01
Abstract: Impact-resistant compositions based on vinyl chloride polymers and their use for the extrusion of sections comprising, as vinyl chloride polymers:   (a) from 3 to 40 parts of vinyl chloride graft copolymer on weakly crosslinked polybutyl acrylate, (b) from 5 to 85 parts of vinyl chloride graft copolymer on a copolymer of ethylene and vinyl acetate and (c) from 10 to 85 parts of unmodified vinyl chloride polymer per 100 parts by weight in total of all the vinyl chloride polymers in the composition, as well as, as reinforcing filler, (d) from 3 to 10 parts of coated calcium carbonate in which the elementary particles have a mean diameter of less than 1  mu m, per 100 parts by weight of all the vinyl chloride polymers in the composition.
Patent FI-941360-A0 (FI)
Inventor: ZABEAU MARC
IPC: C12Q1/6858
Filed: 1994-03-24
Abstract: The invention relates to a process for the controlled amplification of at least one part of a starting DNA containing a plurality of restriction sites for a determined specific restriction endonuclease, and of which at least part of its nucleic acid is unknown. Application of this process to human, animal or plant DNA fingerprinting, to identification of restriction fragment length polymorphisms. Kit for the application of the process.
Patent FI-942929-A0 (FI)
Inventor: LOPEZ GEORGE A
IPC: A61M5/14
Filed: 1994-06-17
Abstract: A closed system, needless valve device includes a generally tubular body (20) defining an internal cavity. On the proximal end of the body there is an opening (25A) which is preferably sufficiently large to receive an ANSI standard tip of a medical implement. The distal end of the body has a generally tubular skirt (16). The valve also includes a hollow spike (24) having a closed tip. The spike includes at least one longitudinal 18-gauge hole (34) located distal the tip, and is seated inside the cavity such that the tip is below the proximal end of the body. An annular support cuff (28) is connected to the spike which seals off a portion of the cavity of the body such that an upper cavity containing the tip is defined. The valve also includes a plastic, resilient silicone seal (36) which fills the upper cavity and opening and covers the tip of the spike so as to present a flush surface. An adaptor enables the valve to be attached to a resealable container. <IMAGE>
Patent IL-59903-A0 (IL)
Title: Preparation of n-phosphonomethyl glycine
IPC: C07F9/40
Filed: 1980-04-23
Abstract: The invention provides a process and the product of process for the preparation of N-phosphonomethyl-glycine comprising the oxidation of an aqueous suspension of N-phosphonomethyl-imino diacetic acid in the presence of a catalyst with oxygen or an oxygen-containing gas. Comparing the process of the invention with the known processes, specific conversion is considerably increased and significant amounts of energy can be saved.
Patent IL-61430-A0 (IL)
Title: Process for the purification of wet-processed phosphoric acid
IPC: C01B25/234
Filed: 1980-11-07
Abstract: The invention relates to a process for the purification of wet-processed phosphoric acid with the aid of organic solvents which are immiscible or only partially miscible with water, the sulfate ions being removed by addition of barium compounds. The purification is carried out in an n-stage extraction installation, where n is equal to or greater than 5. The barium compound is added to the phosphoric acid to be purified, and the resulting mixture is fed to the top of the extraction installation, in which the organic solvent phase is dispersed in the aqueous phase. The sulfuric acid is led in counter-current fashion to the phosphoric acid by adding it to one of the stages n=4 to at most n-1.
Patent IL-62324-A0 (IL)
Title: Preparation of 1,1-dihalogenoalkenes
IPC: C07C21/17
Filed: 1981-03-09
Abstract: In the preparation of a 1,1-dihalogenoalkene of the formula   <IMAGE> in which R1 is a hydrogen atom or an optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, aralkyl, aralkenyl or aryl radical, and R2 is an optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, aralkyl, aralkenyl or aryl radical, or R1 and R2 together form an optionally branched and/or optionally benzo-fused hydrocarbon chain, and X1 and X2 each independently is a halogen atom, wherein a carbonyl compound of the formula   <IMAGE>  is reacted with a trihalogenoacetate of the formula   <IMAGE>   in which X3 is a halogen atom, and M(+) is an alkali metal ion or one equivalent of an alkaline earth metal ion, in the presence of an approximately equimolar amount of a phosphorus-containing compound, the improvement which comprises employing as said phosphorus-containing compound a phosphorous acid trialkyl ester or a phosphorous acid triamide and effecting the reaction at a temperature between about 0 DEG  and 200 DEG  C. A preferred end product is   <IMAGE>  and the preferred phosphorus-containing compound is trimethyl phosphite, triethyl phosphite, tripropyl phosphite or phosphorous acid tris-dimethyl-amide.
Patent IL-70925-A0 (IL)
Title: Mixtures of fsh and lh from pig hypophyses in a definite ratio
IPC: A61K38/24
Filed: 1984-02-10
Abstract: The mixtures of FSH (a follicle stimulating hormone) and LH (a luteinizing hormone) being extracted from pig hypophyses in a definite ratio, improve to an optimum level the induction of super-ovulation in bred animals.
Patent IL-91298-A0 (IL)
Title: Peptides having bradykinin antagonist action
IPC: C07K1/06
Filed: 1989-08-11
Abstract: Peptides of the formula I A-B-C-E-F-K-(D)-Tic-G-M-F'-I (I> in which A is hydrogen, alkyl, alkanoyl, alkoxycarbonyl, alkylsulphonyl, cycloalkyl, aryl, arylsulphonyl, heteroaryl or an amino acid, each of which can optionally be substituted, B is a basic amino acid, C is a di- or tripeptide, E is the residue of an aromatic amino acid, F is, independently of one another, an amino acid which is optionally substituted in the side chain or is a direct bond, G is an amino acid, F' is defined as F, can be -NH-(CH2)2-8 or optionally a direct bond, I is -OH, -NH2 or -NHC2H5 and K is a radical -NH(CH2)-1-4-CO- or is a direct bond, have bradykinin-antagonistic action. Their therapeutic uses comprise all pathological states which are promoted, induced or sustained by bradykinin and bradykinin- related peptides. The peptides of the formula I are prepared by known methods of peptide synthesis.
Patent FI-20041589-A0 (FI)
Inventor: LINDEN JAN
IPC: G01D11/30
Filed: 2004-12-09
Abstract: A measurement sensor includes an elongated sensor part at the first end of which is the electrical connection of the sensor part and at the second end of which is the sensor end of the sensor part. A first sleeve part is arranged around the sensor part for attaching the measurement sensor to the object to be measured and for supporting the sensor part. A second sleeve part extends into the first sleeve part, the second sleeve part being rotatably arranged in connection with the first sleeve part. The sensor part has an external thread and the second sleeve part has an internal thread, the external thread of the sensor part and the internal thread of the second sleeve part are connected to each other so that when the second sleeve part is rotated in relation to the sensor part, the sensor part moves in the direction of its longitudinal axis in relation to the first and second sleeve parts.
Patent IL-100612-A0 (IL)
Title: Cyclic ketal derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61K31/34
Filed: 1992-01-08
Abstract: Compounds are described of the formula <CHEM> These compounds inhibit the enzyme squalene synthase and/or are intermediates for the preparation of compounds which inhibit the enzyme squalene synthase. Compounds of the invention may be formulated for use in a variety of conditions where a lowering of the level of blood plasma cholesterol in animals would be beneficial and for use in combating fungal infections in animals.
Patent IL-101680-A0 (IL)
Title: Blood sampling device
IPC: A61B5/15
Filed: 1992-04-23
Abstract: PCT No. PCT/US93/03787 Sec. 371 Date Apr. 13, 1995 Sec. 102(e) Date Apr. 13, 1995 PCT Filed Apr. 21, 1993 PCT Pub. No. WO93/21821 PCT Pub. Date Nov. 11, 1993A blood sampling system includes a blood collecting assembly having an in-line blood sampling unit, a blood sampling container, and a fluid coupling device coupled to the in-line blood sampling unit for coupling the in-line blood sampling unit to the blood sampling container. The fluid coupling device has a housing having an anterior section formed with an open end capable of being applied to the blood sampling unit, a posterior section formed with an open end capable of receiving the blood sampling container, and a transversely-extending member between the anterior and posterior sections. A needle is secured to the transversely-extending member so as to extend axially of the housing. The needle has anterior and posterior sections extending within the anterior and posterior sections of the housing, respectively, both the anterior and posterior sections of the needle terminating sufficiently short of the open ends of the anterior and posterior sections of the housing to be protected against accidentally puncturing a user's skin. Attaching slots are formed on the housing for attaching the housing to the blood sampling unit with the anterior section of the needle penetrating the blood sampling unit perpendicularly to the flow of blood therethrough.
Patent IL-102118-A0 (IL)
Title: ((arylalkylpiperidin-4-yl)methyl)-2a,3,4,5-tetrahydro-1(2h)-acenaphthylen-1-ones and related compounds,a process for their preparation and their use as medicaments
IPC: C07D211/32
Filed: 1992-06-05
Abstract: There are disclosed various compounds of the formula below <CHEM>  where  X is hydrogen, loweralkyl, loweralkoxy, hydroxy or nitro; Y is hydrogen or loweralkoxy; or alternatively, X ans Y combined together form the group -OCH2O- in which case the positions of X and Y on the benzene ring moiety must be adjacent to each other; Z is hydrogen, loweralkyl, loweralkoxy, hydroxy, halogen or nitro and n is 0 or 1, which compounds are useful for alleviating various memory dysfunction characterizied by a cholinergic deficit such as Alzheimer's disease.
Patent IL-107378-A0 (IL)
Title: Soluble interferon a-receptor, its preparation and use
IPC: A61K38/17
Filed: 1993-10-24
Abstract: New forms of interferon  alpha -receptors are provided. They may be prepared recombinantly and may be used in diagnosis and therapy.
Patent IL-114984-A0 (IL)
Title: Gepirone dosage form
IPC: A61K9/20
Filed: 1995-08-17
Abstract: Pharmaceutical compsn. for making oral extended release gepirone (I) dosage forms comprises: (a) 0.5-12 wt.% (I).HCl; (b) 70-85 wt.% cellulosic polymer matrix; (c) excipients. The release rate of (I) is such that 18-24 hrs. are required to attain 90-95% absorption of (I). Pref. (b) is hydroxypropylmethylcellulose with viscosity 1.5 x 104 - 1 x 106; and (c) is colourant, microcrystalline cellulose, colloidal silica and/or magnesium stearate.
Patent IL-122585-A0 (IL)
Title: Animal feed
IPC: A23K1/18
Filed: 1996-06-14
Abstract: The present invention relates to animal feed with improved quality, improved resistance to undesirable bacterial strains and improved digestibility and to a process for preparing animal feed containing cereal involving cereal fermentation to produce a feed.
Patent IL-132428-A0 (IL)
Title: An improved spraying device
IPC: B05B7/02
Filed: 1998-02-16
Abstract: An improved spraying device for mixing a first fluid with a second fluid prior to dispensing into the environment. The spraying device includes a spraying head connected to a cartridge bottle. A shroud covers the spraying head to cartridge bottle connection. The chemical remains in a closed system even after the cartridge bottle is attached to the spraying head. A unique gear and/or cam system is provided to open the flow path of the second fluid and provide a positive operation. Also, the orifice diameter of the second fluid flow path is predetermined.
Patent IL-134556-A0 (IL)
Title: Bulk conveying system and method of controlling a bulk conveying system
IPC: B65G53/32
Filed: 1998-08-19
Abstract: Bulk conveying system and method of controlling a bulk conveying system. A main conveying pipe (2) connected to the bulk outlet (12) of a main storage container (1) has a pump unit (21) for driving the bulk material through the main conveying pipe (2). A plurality of distribution pipes (3) are connected to the main conveying pipe (2) and equipped with a distribution valve (31) to be opened or closed. A plurality of distribution units (4) are connected to the main conveying pipe (2) through a corresponding one of the distribution pipes (3). Stock level detectors (43) detect whether or not the actual stock level in the distribution unit container (41) is equal to or falls below a predetermined minimum stock level and whether or not it is equal to a predetermined maximum stock level. A conveyance control system (5) controls the distribution valve (31) of each of the distribution pipes (3) and the pump unit (21) on the basis of the detected values.
Patent IL-142482-A0 (IL)
Title: Accessing a hierarchical data store through an sql input
IPC: G06F11/34
Filed: 1999-10-15
Abstract: A method and system for an extensible macro language is provided. The system for providing the extensible macro language includes a parser and a macro handler for processing macro commands not previously defined in the macro language. The parser analyzes keywords in a macro language expression and recognizes one or more keywords representing macro commands that were not previously defined in the macro language. The macro handler receives the keywords in the macro expression and retrieves from a registry of keywords, an executable code or procedure associated with the keyword. The executable code is run to process the macro command represented by the keyword. The template language registry may be augmented to include any keywords and associated codes for extending the macro language.
Patent IL-147447-A0 (IL)
Title: Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
IPC: A61K39/00
Filed: 2000-06-24
Abstract: Chimeric human-bovine respiratory syncytial virus (RSV) are infectious and attenuated in humans and other mammals and useful in vaccine formulations for eliciting an anti-RSV immune response. Also provided are isolated polynucleotide molecules and vectors incorporating a chimeric RSV genome or antigenome which includes a partial or complete human or bovine RSV “background” genome or antigenome combined or integrated with one or more heterologous gene(s) or genome segment(s) of a different RSV strain. In preferred aspects of the invention, chimeric RSV incorporate a partial or complete bovine RSV background genome or antigenome combined with one or more heterologous gene(s) or genome segment(s) from a human RSV. A variety of additional mutations and nucleotide modifications are provided within the human-bovine chimeric RSV of the invention to yield desired phenotypic and structural effects.
Patent IL-193996-A0 (IL)
Title: Neuromedin u receptor agonists and uses thereof
Filed: 2008-09-09
Abstract: Neuromedin U receptor agonists for use in the treatment of metabolic disorders such as obesity and diabetes are disclosed.
Patent IL-228987-A0 (IL)
Title: Protein purification by ion exchange chromatography
IPC: C07K1/18
Filed: 2013-10-21
Abstract: A method for purifying a polypeptide by ion exchange chromatography is described which involves changing the conductivity and/or pH of buffers in order to resolve a polypeptide of interest from one or more contaminants.
Patent RO-129052-A0 (RO)
Title: Combined fodder for phase-related feeding of chickens for meat
Inventor: MIERLITA DANIEL
IPC: A23K1/14
Filed: 2013-01-11
Abstract: The invention relates to a fodder intended for feeding chickens for meat. According to the invention, the fodder comprises maize as grains, soya beans grit, white lupin flour, commercial fat, a mixture of enzymes and vitamins and minerals premix.
Patent CU-22471-A1 (CU)
Title: Separador de aceite
Inventor: WONG RUIZ JOSE DE JESUS
IPC: F25B43/02
Filed: 1994-12-05
Abstract: Se trata de un separador de aceite del refrigerante líquido, que particularmente puede ser parte integrante de una instalación frigorífica, compuesto por dos bloques: uno primero, donde se ordena los dos componentes de la mezcla en campos bien definidos para facilitar y hacer más eficiente su separación ulterior, constituido por un cuerpo en forma de cono invertido conformado de un serpentín de tubo rectangular con una entrada y una salida de la mezcla tangenciales con respecto al cuerpo, y ubicadas en su parte superior e inferior respectivamente, esta última unida al segundo bloque, donde finalmente se separa la mezcla, constituido por un hidrociclón, cuya entrada tangencial de la mezcla posee la misma forma rectangular del serpentín del primer bloque.
Patent IE-910489-A1 (IE)
Title: Thin film electrical component with polymer substrate
Inventor: HELLER JAMES WALTER
IPC: H01L27/01
Filed: 1991-02-13
Abstract: A biocompatible thin film electrical component is configured for use in a human body or other ionic liquid environment. A polyimide substrate (11) is bonded to a glass carrier plate (10) sized for handling by automatic equipment and a multiple-layer metal conductor (18) is deposited on the substrate and patterned to define an electrical circuit or biosensor. The polyimide and the glass establish a bond therebetween that withstands handling yet is broken using biocompatible releasing agents and techniques. The polyimide substrate and glass carrier plate preferably have similar thermal expansion properties to reduce the likelihood of fracture and delamination problems during release of the substrate from the carrier plate. An insulation layer (28) covers the metal conductor and, in one embodiment, is made of a polyimide having a cure temperature lower than the temperature at which interdiffusion occurs in the metal layers in the conductor.
Patent LU-81512-A1 (LU)
Inventor: BAUMERT J
IPC: C21C5/30
Filed: 1979-07-16
Abstract: A method of and an apparatus for determining the level of slag above a metallurgical melt, especially a steel melt, and for determining a physical characteristic or property of the slag, such as its viscosity or consistency, utilizes a plurality of nozzles opening into the bath-containing vessel at different levels above the melt and supplied with inert gas. The difference in hydrostatic pressures at the nozzles can be ascertained by measurement of the pressures upstream thereof and the measured values are converted into indications of slag level and consistency.
Patent MA-24984-A1 (MA)
Title: Composition detergente granulaire ayant un aspect et une solubilite ameliores
Inventor: JACQUELINE WESTFIELD
IPC: C11D17/06
Filed: 1999-09-24
Abstract: UNE COMPOSITION DÉTERGENTE QUI A UNE MEILLEURE SOLUBILITÉ OU UNE MEILLEURE DISSOLUTION DANS DES SOLUTIONS DE LAVAGE DE LINGE, EN PARTICULIER DANS DES SOLUTIONS MAINTENUES AUX BASSES TEMPÉRATURES (C'EST-à-DIRE INFÉRIEURES à ENVIRON 3Oo.C) EST DÉCRITE DANS LA PRÉSENTE DESCRIPTION. LA COMPOSITION DÉTERGENTE GRANULAIRE EST ESTHÉTIQUEMENT PLAISANTE POUR LES CONSOMMATEURS ET à UNE MEILLEURE RHÉOLOGIE. LA COMPOSITION DÉTERGENTE GRANULAIRE A UN NIVEAU CHOISI DE MANIèRE OPTIMALE DE PARTICULES AYANT UN DIAMèTRE PARTICULAIRE MOYEN CHOISI DE MANIèRE JUDICIEUSE AVEC UN ÉCART-TYPE SÉLÉCTIONNÉ. LA COMPOSITION DÉTERGENTE GRANULAIRE A ÉGALEMENT DES PROPRIÉTÉS PHYSIQUES TAILLÉES SOIGNEUSEMENT SUR MESURE, TELLES QUE LE PARAMèTRE D'UNIFORMITÉ, LA BLANCHEUR,  LA CIRCULARITÉ ET LE RAPPORT D'ASPECT.
Patent MA-25958-A1 (MA)
Inventor: LIN WEIQI
IPC: A61K31/662
Filed: 2003-04-07
Abstract: This invention relates to a method for inhibiting a decrease in the transdermal flux of an agent that is being transdermally delivered or sampled over a prolonged period of time wherein the delivery or sampling involves disrupting at least the stratum corneum layer of the skin to form pathways through which the agent passes. The desired result is achieved by co-delivering or co-sampling the agent with an amount of at least one anti-healing agent wherein the amount of the anti-healing agent is effective in inhibiting a decrease in the agent transdermal flux compared to when the delivery or sampling of the agent is done under substantially identical conditions except in the absence of the anti-healing agent(s).
Patent MA-26269-A1 (MA)
Inventor: MONTEBRUNO LIDIA
IPC: H04W84/20
Filed: 2003-09-01
Abstract: A telecommunications network for mobile users includes a user subsystem and a transport subsystem connected to an access subsystem. The access subsystem provides a user access communications interface and a transport access communications interface for exchange of information among the subsystems. The access subsystem is identified with a coverage area of the cellular telecommunication network. The access subsystem is associated with interconnection means in order to receive second information signals broadcast from one or more geostationary satellites and send them via the telecommunications network for mobile users to users located within the coverage area of the mobile telecommunications network.
Patent MA-38047-A1 (MA)
Title: Port de charge spécialisé pour la haute tension
Inventor: HAWAWINI SHADI
IPC: H02J7/00
Filed: 2013-10-25
Abstract: Selon la présente invention, des circuits dans un dispositif électronique peuvent être reliés à un dispositif externe, tel qu'une alimentation électrique, pour recevoir une tension à un niveau de tension souhaité en provenance du dispositif externe. Les circuits peuvent activer une configuration parmi plusieurs configurations électriques sur le câblage qui connecte électriquement le dispositif portable au dispositif externe afin d'indiquer au dispositif externe un niveau de tension souhaité.